Skip to content or main menu

Erase MS

Laquinimod

Advances in Oral Drugs for Multiple Sclerosis

August 1, 2011

Today, Teva Pharmaceuticals had mixed reports to share regarding laquinimod, an experimental, oral drug for Multiple Sclerosis.

Click here to read more about the clinical study and other oral treatments for Multiple Sclerosis.

Read More »

Latest News - view all

Increase Risk for MS linked to Oral Contraceptives

Posted: Mar 01, 2014Utilizing membership data from Kaiser Permanente Southern California, researchers analyzed the health records of 305 women aged ...

Find us on Facebook. Follow us on Twitter. YouTube. Pinterest. Subscribe to our RSS feed.

Copyright | Site By Urban Jungle | Powered by Inflight